2nd Annual UNMC Transplant Symposium

At the conclusion of this activity, the participants should be better able to:

1. Review the current state-of-the-art approach to interdisciplinary care in solid organ transplantation.
2. Evaluate emerging research, trends, and clinical practices related to solid organ transplantation.
3. Identify opportunities for clinical and research collaboration, discovery, and program development in solid organ transplantation.

This accredited continuing education activity is designed for physicians, advanced practice providers, nurses, pharmacists, dietitians, transplant coordinators, fellows, residents, and students in solid organ transplantation.

In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The University of Nebraska Medical Center designates this live activity for a maximum of 9.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses

The University of Nebraska Medical Center designates this activity for 9.75 ANCC contact hours. Nurses should only claim credit for the actual time spent participating in the activity.

Pharmacists

The University of Nebraska Medical Center designates this activity for 9.75 ACPE contact hours. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. UAN # JA0000319-0000-25-003-L01-P

Transplant Coordinators

As a designated Approved Provider by the American Board of Transplant Certification (ABTC), Nebraska Medicine grants up to 9.75 Category I Continuing Education Points for Transplant Certification (CEPTCs) for this offering. Code #117-245

Poster Session: Abstracts will be featured in poster sessions, where presenters can engage in interactive discussions with attendees.

• The symposium organizer will provide a display board for your poster (recommended size: 48" x 48").
• Presenters must bring their assembly materials (pushpins, Velcro, tape, etc.).

Read the UNMC CCE Disclosure Declaration Policy 

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following have disclosed relevant financial relationships:

• Heidi Brink, PharmD, BCPS, BCCP, DPLA
  Advisor: Merck & Co, Inc.
• Carlos A. Gomez, MD*
  Consultant: Karius, Inc.
  Research Grant: Eagle Pharmaceuticals, Inc.; SymBio Pharmaceuticals Limited
• Kelsey Klute, MD
  Consultant: Agenus Inc; Oncolys BioPharma Inc.
  Research Funding: AIM ImmunoTech; Cardiff Oncology, Inc.
  Speaker: National Comprehensive Cancer Network (NCCN)
• Keren Ladin, PhD, MSc
  Fellow, Reviewer: Greenwall Foundation
  Principal Investigator, Grant: Dialysis Clinic, Inc (DCI); Paul Teschan Research Fund; Patient-Centered Outcomes Research Institute (PCORI)
• Eric Langewisch, MD
  Principal Investigator: CSL; Biogen; CareDx
  Sub-Investigator: Eledon Pharmaceuticals, Inc.; ITB-MED
  INVESTIGATIONAL/OFF-LABEL USE OF DRUGS DISCLOSURE
  Immunosuppressive medications Siplizumab, Clazakizumab, Tegoprubart, Abatacept, and Felzartamab for use in preventing or treating transplant rejection
• Mary Leick, PharmD, DPLA, BCPS, BCTXP*
  Consultant: Dynamed (EBSCO Industries)
• Roslyn B. Mannon, MD*
  Consultant: Alexion Pharmaceuticals, Inc.; CSL; Eledon Pharmaceuticals, Inc.; Biogen (Hi Bio); Verici DX
  Grant: Verici DX
• Shaheed Merani, MD, PhD, FRCS(C), FACS*
  Principal Investigator: CareDx, Paragonix(A Getinge company), TransMedics
• Faruq Pradhan, MBBCh, FRCPC*
  Advisory Board: Madrigal Pharmaceuticals
• Ruben E. Quiros, MD*
  Consultant: Mirum

 

The following have nothing to disclose:

• Jenna Allison, MD
• Michael A. Ash, MD
• Brian J. Benes, DO*
• Ashley N. Brabec, MS, RD, LMNT*
• Kimberly Butler, BSN, RN
• Kari Caldwell, BSN, RN, CCTC
• Jesse L. Cox, MD, PhD, A(ACHI)
• Camille L. Hancock-Friesen, MD
• Kyle Herber
• Arika L. Hoffman, MD
• Charlotte M. Hunt, PA-C
• Marshall Hyden II, MD
• Alan N. Langnas, DO, FACS*
• Brian Lowes, MD, PhD*
• Michael J. Moulton, MD, FACS
• Marco A. Olivera-Martinez, MD
• Jessica L. Reeb, APRN, FNP-BC
• Emille Reyes-Santiago, MD
• Fedja A. Rochling, MB, BCh, (NUI), MBA
• Nora E. Sarvetnick, PhD
• Heather Strah, MD
• Veronica A. Taylor, MD
• John Y. Um, MD, FACS, FACC
• Stacie Williams, BSN, RN, CCTC
• Kari K. Zelenka, MSN, MBA, RN, CCRN

PLANNING COMMITTEE

The following has disclosed a relevant financial relationship:

• Morgan Moody, BSN
  Speaker: Abbott

The following have nothing to disclose:

•  Katherine Brodahl, PA-C
• Valeta Creason-Wahl, MMP
• Mary Clark, MSN, RN, CCTC
• Tori Greenlee
• Tracy Hanzek
• Julie Huglin
• Heidi Keeler, PhD, MSN/MBA, RN
• Jodi Kennedy
• Renee Paulin, MSN, RN, CWOCN
• Brenda Ram, CMP, CHCP
• Jennifer Rounds, DNP, APRN-NP
• Jacqueline Siebels, BSN, RN, NPD-BC
• Shannan Wilson, RRT

 

*Faculty and planning committee member

The following materials (in PDF) are available for download until April 11, 2025. No part of these materials may be reproduced without prior written permission.

Friday, March 21

Current Status of Clinical Programs I

• Kidney and Pancreas
  Brian J. Benes, DO
• Heart
  Brian Lowes, MD, PhD
• Lung
  Michael J. Moulton, MD, FACS
• Liver and Intestine
  Marco A. Olivera-Martinez, MD
• Live On Nebraska
  Kyle Herber
• Pediatric Heart
  Camille L. Hancock-Friesen, MD

 Current Status of Clinical Programs II

• Pediatric Kidney
  Veronica A. Taylor, MD
• Pediatric Liver
  Emille Reyes-Santiago, MD
• Pediatric Intestine
  Ruben E. Quiros, MD
• Regenerative Medicine
  Nora E. Sarvetnick, PhD

Emerging Topics in Transplantation

• Organizing a Living Donor Kidney Chain
  Arika L. Hoffman, MD
• Heart Transplantation in Amyloid
  Marshall Hyden II, MD
• Checkpoint Inhibitors and Liver Transplant: The Next Chapter for Hepatocellular Carcinoma (HCC)
  Kelsey Klute, MD

Case Presentations

• Ethics in Pediatric Kidney Transplantation
  Veronica A. Taylor, MD
• Challenging Case in Pediatric Liver-Intestine Transplantation
  Emille Reyes-Santiago, MD
• Improving Access to Transplant/Hepatobiliary Care Through Regional Outreach Clinics
  Kimberly Butler, BSN, RN and Stacie Williams, BSN, RN, CCTC
• Myeloma Kidney Transplant Candidate
  Charlotte M. Hunt, PA-C
• Obesity in Transplant: Beyond the Weight
  Ashley N. Brabec, MS, RD, LMNT
• Smoking and Transplantation
  Kari Caldwell, BSN, RN, CCTC

Keynote Presentation

• Rethinking Rationing and Access to Transplant: Achieving Transparency and Reliability by Uniting Stakeholders in Transplant Decision-Making – Preliminary Results from the TRUST Study
  Keren Ladin, PhD, MSc

Saturday, March 22

Preparing for the Future: Research in Transplantation

• Next-Generation Sequencing (NGS) in Infectious Disease Diagnostics: Transforming Care for Immunocompromised Transplant Patients
  Carlos A. Gomez, MD
• Continuous Distribution in Lung Transplant
  Heather Strah, MD
• Cold Preservation in Heart Transplantation
  John Y. Um, MD, FACS, FACC

Ethics in Transplantation

• Ethics in Transplantation
  Keren Ladin, PhD, MSc

Opportunities for the Future of Transplantation

• An Update in Pathology for Solid Organ Transplantation
  Jesse L. Cox, MD, PhD, A(ACHI)
• Novel Immunosuppression in Kidney Transplantation
  Eric Langewisch, MD
• Chemo Therapy, Targeted Therapy, Immunotherapy, Oh My! Oncology Implications in Solid Organ Transplant Pharmacology
  Heidi Brink, PharmD, BCPS, BCCP, DPLA
• Adjuvant Chemotherapy for Hepatoblastoma After Liver Transplant
  Jenna Allison, MD